Twitter response to the 2018 US Preventive Services Task Force guidelines on prostate cancer screening

BJU Int. 2019 Sep;124(3):363-364. doi: 10.1111/bju.14734. Epub 2019 Mar 27.

Authors

Yaohan Ke¹, Jacob Taylor², Lingshan Gao¹, Hezhi Wang¹, Han Zhao¹, Nataliya Byrne^{2

3}, Vaibhav Modgil⁴, Mohit Butaney⁵, Danil V Makarov^{2

3

6}, Vinay Prabhu⁷, Stacy Loeb^{2

3

6}

Affiliations

¹ Center for Data Science, New York University, New York, NY, USA.
² Department of Urology, New York University School of Medicine, New York, NY, USA.
³ Department of Population Health, New York University School of Medicine, New York, NY, USA.
⁴ University College London Hospitals NHS Foundation Trust, London, UK.
⁵ Royal College of Surgeons, Dublin, Ireland.
⁶ Urology Service, Manhattan Veterans Affairs, New York, NY, USA.
⁷ Department of Radiology, New York University School of Medicine, New York, NY, USA.

PMID: 30811805
DOI: 10.1111/bju.14734

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Advisory Committees
Early Detection of Cancer
Humans
Male
Prostate-Specific Antigen
Prostatic Neoplasms*
Social Media*

Substances

Prostate-Specific Antigen